3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 13, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 5, 2015

Conditions
Immunization, Booster
Interventions
BIOLOGICAL

1/3 IPV-Al SSI, manufactured by SSI, Denmark

Intramuscular injection of 0.5 mL vaccine into deltoid muscle

BIOLOGICAL

1/5 IPV-Al SSI, manufactured by SSI, Denmark

Intramuscular injection of 0.5 mL vaccine into deltoid muscle

BIOLOGICAL

1/10 IPV-Al SSI, manufactured by SSI, Denmark

Intramuscular injection of 0.5 mL vaccine into deltoid muscle

BIOLOGICAL

IPV SSI, manufactured by SSI, Denmark

Intramuscular injection of 0.5 mL vaccine into deltoid muscle

Trial Locations (3)

DK-9000

CCBR, Aalborg

DK-2750

CCBR, Ballerup Municipality

DK-7100

CCBR, Vejle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

CCBR Clinical Research

UNKNOWN

collaborator

Larix A/S

INDUSTRY

lead

Statens Serum Institut

OTHER

NCT02280447 - 3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents | Biotech Hunter | Biotech Hunter